Michael M. Lipp

1.7k total citations
22 papers, 1.4k citations indexed

About

Michael M. Lipp is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Atomic and Molecular Physics, and Optics. According to data from OpenAlex, Michael M. Lipp has authored 22 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Pulmonary and Respiratory Medicine and 6 papers in Atomic and Molecular Physics, and Optics. Recurrent topics in Michael M. Lipp's work include Lipid Membrane Structure and Behavior (9 papers), Surfactants and Colloidal Systems (5 papers) and Spectroscopy and Quantum Chemical Studies (5 papers). Michael M. Lipp is often cited by papers focused on Lipid Membrane Structure and Behavior (9 papers), Surfactants and Colloidal Systems (5 papers) and Spectroscopy and Quantum Chemical Studies (5 papers). Michael M. Lipp collaborates with scholars based in United States, Germany and Israel. Michael M. Lipp's co-authors include Joseph A. Zasadzinski, Alan J. Waring, Dawn Y. Takamoto, Ka Yee C. Lee, A. von Nahmen, Róbert Langer, Noah Lotan, Ramsey C. Kinney, Daniel S. Kohane and Junqi Ding and has published in prestigious journals such as Science, Physical Review Letters and SHILAP Revista de lepidopterología.

In The Last Decade

Michael M. Lipp

22 papers receiving 1.4k citations

Peers

Michael M. Lipp
Dawn Y. Takamoto United States
Junqi Ding United States
Peter G. Petrov United Kingdom
Oleg Y. Grinberg United States
Michael M. Lipp
Citations per year, relative to Michael M. Lipp Michael M. Lipp (= 1×) peers Manfred Sieber

Countries citing papers authored by Michael M. Lipp

Since Specialization
Citations

This map shows the geographic impact of Michael M. Lipp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael M. Lipp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael M. Lipp more than expected).

Fields of papers citing papers by Michael M. Lipp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael M. Lipp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael M. Lipp. The network helps show where Michael M. Lipp may publish in the future.

Co-authorship network of co-authors of Michael M. Lipp

This figure shows the co-authorship network connecting the top 25 collaborators of Michael M. Lipp. A scholar is included among the top collaborators of Michael M. Lipp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael M. Lipp. Michael M. Lipp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lipp, Michael M., Anthony J. Hickey, Róbert Langer, & Peter A. LeWitt. (2021). A technology evaluation of CVT-301 (Inbrija): an inhalable therapy for treatment of Parkinson’s disease. Expert Opinion on Drug Delivery. 18(11). 1559–1569. 11 indexed citations
2.
Edwards, David A., Anthony J. Hickey, Richard Batycky, et al.. (2020). A New Natural Defense Against Airborne Pathogens. SHILAP Revista de lepidopterología. 1. e5–e5. 12 indexed citations
3.
Lipp, Michael M., Richard Batycky, Jerome A. Moore, Mika Leinonen, & Martin I. Freed. (2016). Preclinical and clinical assessment of inhaled levodopa for OFF episodes in Parkinson’s disease. Science Translational Medicine. 8(360). 360ra136–360ra136. 59 indexed citations
4.
Hallacli, Erinc, Michael M. Lipp, Plamen Georgiev, et al.. (2012). Msl1-Mediated Dimerization of the Dosage Compensation Complex Is Essential for Male X-Chromosome Regulation in Drosophila. Molecular Cell. 48(4). 587–600. 38 indexed citations
5.
Kadlec, Jan, Erinc Hallacli, Michael M. Lipp, et al.. (2011). Structural basis for MOF and MSL3 recruitment into the dosage compensation complex by MSL1. Nature Structural & Molecular Biology. 18(2). 142–149. 85 indexed citations
6.
Hava, David L., Nancy A. Jewell, Anson T. Ku, et al.. (2011). Inhaled Cationic Salts Inhibit Infection Of Multiple Viral Pathogens And Prevent Influenza Infection In Vivo. A3369–A3369. 2 indexed citations
7.
Kohane, Daniel S., Michael M. Lipp, Ramsey C. Kinney, et al.. (2001). Biocompatibility of lipid‐protein‐sugar particles containing bupivacaine in the epineurium. Journal of Biomedical Materials Research. 59(3). 450–459. 91 indexed citations
8.
Takamoto, Dawn Y., Michael M. Lipp, A. von Nahmen, et al.. (2001). Interaction of Lung Surfactant Proteins with Anionic Phospholipids. Biophysical Journal. 81(1). 153–169. 186 indexed citations
9.
Ding, Junqi, Dawn Y. Takamoto, A. von Nahmen, et al.. (2001). Effects of Lung Surfactant Proteins, SP-B and SP-C, and Palmitic Acid on Monolayer Stability. Biophysical Journal. 80(5). 2262–2272. 154 indexed citations
10.
Lee, Ka Yee C., Jarosław Majewski, Tonya L. Kuhl, et al.. (2001). Synchrotron X-Ray Study of Lung Surfactant-Specific Protein SP-B in Lipid Monolayers. Biophysical Journal. 81(1). 572–585. 67 indexed citations
11.
Gordon, Larry M., Michael M. Lipp, Joseph A. Zasadzinski, et al.. (2000). Conformational mapping of the N‐terminal segment of surfactant protein B in lipid using 13C‐enhanced Fourier transform infrared spectroscopy. Journal of Peptide Research. 55(4). 330–347. 78 indexed citations
12.
Kohane, Daniel S., Michael M. Lipp, Ramsey C. Kinney, Noah Lotan, & Róbert Langer. (2000). Sciatic Nerve Blockade with Lipid-Protein-Sugar Particles Containing Bupivacaine. Pharmaceutical Research. 17(10). 1243–1249. 54 indexed citations
13.
Majewski, Jarosław, Tonya L. Kuhl, Paul B. Howes, et al.. (1999). The Incorporation of Lung Surfactant Specific Protein SP-B Into Lipid Monolayers at the Air-Fluid Interface: A Grazing Incidence x-ray Diffraction Study. MRS Proceedings. 590. 3 indexed citations
14.
15.
Lee, Ka Yee C., Michael M. Lipp, Joseph A. Zasadzinski, & Alan J. Waring. (1998). <title>Direct observation of phase and morphology changes induced by lung surfactant protein SP-B in lipid monolayers via fluorescence, polarized fluorescence, Brewster angle, and atomic force microscopies</title>. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 3273. 115–133. 5 indexed citations
16.
Lipp, Michael M., et al.. (1997). Fluorescence, polarized fluorescence, and Brewster angle microscopy of palmitic acid and lung surfactant protein B monolayers. Biophysical Journal. 72(6). 2783–2804. 88 indexed citations
17.
Lee, Ka Yee C., Michael M. Lipp, Joseph A. Zasadzinski, & Alan J. Waring. (1997). Effects of lung surfactant specific protein SP-B and model SP-B peptide on lipid monolayers at the air-water interface. Colloids and Surfaces A Physicochemical and Engineering Aspects. 128(1-3). 225–242. 27 indexed citations
18.
Lipp, Michael M., Ka Yee C. Lee, Joseph A. Zasadzinski, & Alan J. Waring. (1997). Design and performance of an integrated fluorescence, polarized fluorescence, and Brewster angle microscope/Langmuir trough assembly for the study of lung surfactant monolayers. Review of Scientific Instruments. 68(6). 2574–2582. 42 indexed citations
19.
Lipp, Michael M., Ka Yee C. Lee, Joseph A. Zasadzinski, & Alan J. Waring. (1997). Solving medical problems with chemical engineering. 27(3). 42–57. 2 indexed citations
20.
Lipp, Michael M., et al.. (1996). Phase and Morphology Changes in Lipid Monolayers Induced by SP-B Protein and Its Amino-Terminal Peptide. Science. 273(5279). 1196–1199. 140 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026